Breaking News Instant updates and real-time market news.

OSTK

Overstock.com

$7.88

-0.2 (-2.48%)

09:25
11/20/19
11/20
09:25
11/20/19
09:25

Overstock.com to host analyst & investor day

Analyst & Investor Day to be held in New York on November 20 at 10 am. Webcast Link

  • 20

    Nov

OSTK Overstock.com
$7.88

-0.2 (-2.48%)

07/16/19
MAXM
07/16/19
INITIATION
Target $34
MAXM
Buy
Overstock.com resumed with a Buy at Maxim
Maxim analyst Allen Klee resumed coverage of Overstock.com with a Buy rating, saying he expects the company's Retail e-commerce segment to shift to EBITDA profitability and for its blockchain tZero assets to gain "multiple product approvals" this year. The analyst notes that his price target of $34 is reduced from $75 under prior coverage and reflects expectations of a slower pick-up for tZERO as well as greater Medici projected losses, but believes that the blockchain investment has the potential to be a significant earnings contributor in the longer term.
09/19/19
DADA
09/19/19
NO CHANGE
Target $48
DADA
Buy
Overstock.com stake sale by former CEO Byrne a positive, says DA Davidson
DA Davidson analyst Tom Forte keeps his Buy rating and $48 price target on Overstock.com, saying that he remains confident in its financial services market disruption potential despite the recent "setbacks". The analyst cites the company's announcement that investors can trade the dividend in its Series A-1 Preferred Stock immediately rather than after a 6-month holding period as well as last night's Form 4 disclosure that its former CEO and founder Patrick Byrne cashed out his 4.7M share holding. Forte maintains however that the latter development is a positive for the company as it minimizes Byrne's influence as Overstock's largest shareholder and also increases the likelihood of a sale of its retail business. The analyst still expects the company's current CEO Jonathan Johnson to unlock "meaningful value" from its legacy home e-commerce business and its blockchain technology portfolio.
09/26/19
BOFA
09/26/19
INITIATION
Target $75
BOFA
Buy
Aaron's initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Jason Haas initiated Aaron's (AAN) with a Buy rating and a price target of $75. The analyst expects the company to produce "significant upside" to revenue and EPS from the large national retailer partnerships in its Progressive Leasing segment, adding that its rent-to-own contracts through Best Buy (BBY), Lowe's (LOW), Wayfair (W) and Overstock (OSTK) could more than double the company's sales and earnings over time.
11/13/19
DADA
11/13/19
NO CHANGE
Target $25
DADA
Buy
Overstock.com price target lowered to $25 from $48 at DA Davidson
DA Davidson analyst Tom Forte lowered his price target on Overstock.com to $25 to reflect the "stress test" of his sum-of-parts valuation analysis, but keeps his Buy rating on the stock and remains "comfortable" in recommending it to investors based on the "value" in the shares. Forte lowers his assumed legacy business value to $6 per share from $23 and also reduces his tZero value to $13 from $23. The analyst also looks ahead to the company's November 20th analyst day for more discussion about its performance and its Medici Ventures portfolio.

TODAY'S FREE FLY STORIES

KMI

Kinder Morgan

$19.45

0.15 (0.78%)

11:45
12/05/19
12/05
11:45
12/05/19
11:45
Options
Kinder Morgan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNSS

Sunesis

$0.24

-0.1499 (-38.45%)

11:44
12/05/19
12/05
11:44
12/05/19
11:44
Hot Stocks
Sunesis announces data from ongoing Phase 1b/2 trial of vecabrutinib »

Sunesis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

BIIB

Biogen

$286.74

-2.61 (-0.90%)

11:39
12/05/19
12/05
11:39
12/05/19
11:39
Hot Stocks
Biogen down 3% as trading resumes, medical conference presentation continues »

Biogen representatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

SAGE

Sage Therapeutics

$63.85

-85.37 (-57.21%)

11:38
12/05/19
12/05
11:38
12/05/19
11:38
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VST

Vistra Energy

$24.45

-0.66 (-2.63%)

11:35
12/05/19
12/05
11:35
12/05/19
11:35
Options
Vistra Energy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:35
12/05/19
12/05
11:35
12/05/19
11:35
General news
Today's U.S. reports »

Today's U.S. reports…

BIIB

Biogen

$286.74

-2.61 (-0.90%)

11:35
12/05/19
12/05
11:35
12/05/19
11:35
Hot Stocks
Breaking Hot Stocks news story on Biogen 

Biogen trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

11:30
12/05/19
12/05
11:30
12/05/19
11:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

ACAD

Acadia

$51.31

7.09 (16.03%)

11:25
12/05/19
12/05
11:25
12/05/19
11:25
Recommendations
Acadia analyst commentary  »

Acadia's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBT

Global Blood Therapeutics

$75.73

1.43 (1.92%)

11:25
12/05/19
12/05
11:25
12/05/19
11:25
Options
Global Blood Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 26

    Feb

SRC

Spirit Realty

$52.25

-0.82 (-1.55%)

11:25
12/05/19
12/05
11:25
12/05/19
11:25
Conference/Events
Spirit Realty to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

QUIK

QuickLogic

$0.25

(0.00%)

11:22
12/05/19
12/05
11:22
12/05/19
11:22
Hot Stocks
QuickLogic announces death of Chairman E. Thomas Hart »

QuickLogic earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

SPXC

SPX Corporation

$48.37

0.245 (0.51%)

11:19
12/05/19
12/05
11:19
12/05/19
11:19
Conference/Events
SPX Corporation management to meet with Sidoti »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SAGE

Sage Therapeutics

$65.72

-83.5 (-55.96%)

11:19
12/05/19
12/05
11:19
12/05/19
11:19
Recommendations
Sage Therapeutics analyst commentary  »

Stifel cuts Sage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXT

Sensient

$63.45

0.24 (0.38%)

11:17
12/05/19
12/05
11:17
12/05/19
11:17
Conference/Events
Sensient management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

BIIB

Biogen

$286.74

-2.61 (-0.90%)

11:17
12/05/19
12/05
11:17
12/05/19
11:17
Hot Stocks
Biogen finalizing details of a re-dosing study for aducanumab »

In slides for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
12/05/19
12/05
11:17
12/05/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAVN

Raven

$34.96

-0.01 (-0.03%)

11:16
12/05/19
12/05
11:16
12/05/19
11:16
Conference/Events
Raven management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
12/05/19
12/05
11:16
12/05/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEI

American Public Education

$24.77

-0.32 (-1.28%)

11:15
12/05/19
12/05
11:15
12/05/19
11:15
Conference/Events
American Public Education management to meet with Sidoti »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

11:15
12/05/19
12/05
11:15
12/05/19
11:15
General news
Treasury announced $78 B in 3-, 10-, and 30-year maturities »

Treasury announced $78 B…

11:15
12/05/19
12/05
11:15
12/05/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
12/05/19
12/05
11:15
12/05/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
12/05/19
12/05
11:15
12/05/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

11:15
12/05/19
12/05
11:15
12/05/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.